Gujarat Themis Biosyn logo

Gujarat Themis Biosyn MD, chairman, board of directors and AGM

NSE: GUJTHEMBSE: 506879Pharmaceuticals & BiotechnologySmall Cap

Last close ₹324.00down ₹29.40 (8.32%)BSE ₹327.25

Share price at the NSE close on 23 Oct 2026. Previous close ₹353.40.

52-week range of traded prices to 23 Oct 2026
₹225.05Low, 30 Mar 2026₹479.00High, 27 Oct 2025
Market cap
₹4,217 Cr886th largest listed
P/E
86.6
P/B
Shares changed
Dividend yield
0.21%
ROE
18.2%
ROCE
15.1%
Debt to equity
0.56
Volume, NSE
9,32,72750.2% delivered

Gujarat Themis Biosyn board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonDinesh Shantilal PatelRelated to the promoter
  • Managing directorSachin Dinesh Patel
  • Company Secretary and Compliance OfficerMr. Vineet Gawankar

7 directors4 independent1 executive2 non-executive

  • Dinesh Shantilal Patel · ChairpersonNon-executive · joined May 1992 · reappointed May 1992 · 2 listed boards · 1 committee seat, 1 as chair
  • Sachin Dinesh Patel · Managing directorExecutive · joined Jul 2025 · 2 listed boards · 4 committee seats
  • Kirandeep MadanIndependent · joined May 2021 · reappointed May 2026 · 66 months as independent · 1 listed board · 1 as independent
  • Hitesh Dharmasinh GajariaIndependent · joined May 2024 · 28 months as independent · 2 listed boards · 2 as independent · 2 committee seats, 2 as chair
  • K.G. AnathakrishnanIndependent · joined Jul 2024 · 26 months as independent · 3 listed boards · 3 as independent · 3 committee seats, 1 as chair
  • Nihar Ajay ParikhIndependent · joined Aug 2025 · 14 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • Rajneesh Kedarnath AnandNon-executive · joined Nov 2025 · 2 listed boards · 2 committee seats

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

1 director who left
  • Siddharth Yogesh Kusumgar, left 20 Sep 2025: Tenure Completion

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 10 Sep 20266 of 7 present3 independent · 8 days in between
    • 1 Sep 20266 of 7 present4 independent · 6 days in between
    • 25 Aug 20266 of 7 present4 independent · 17 days in between
    • 7 Aug 20265 of 7 present2 independent · 61 days in between
    1 earlier meeting
    • 6 Jun 20266 of 7 present4 independent

  • Audit Committee

    Chair Hitesh Dharmasinh Gajaria

    Sachin Dinesh Patel, K.G. Anathakrishnan, Nihar Ajay Parikh

    • 7 Aug 20264 of 4 present3 independent · 73 days in between
    • 25 May 20264 of 4 present3 independent

  • Nomination and remuneration committee

    Chair Hitesh Dharmasinh Gajaria

    Dinesh Shantilal Patel, Nihar Ajay Parikh

    No meeting listed in the filing.

  • Stakeholders Relationship Committee

    Chair Dinesh Shantilal Patel

    Sachin Dinesh Patel, Nihar Ajay Parikh, Rajneesh Kedarnath Anand

    No meeting listed in the filing.

  • Risk Management Committee

    Chair Sachin Dinesh Patel

    Rajneesh Kedarnath Anand, Nihar Ajay Parikh

    No meeting listed in the filing.

  • Corporate Social Responsibility Committee

    Chair Dinesh Shantilal Patel

    Sachin Dinesh Patel, Nihar Ajay Parikh, Rajneesh Kedarnath Anand

    No meeting listed in the filing.

  • Fund Raising Committee

    Chair Dinesh Shantilal Patel

    Hitesh Dharmasinh Gajaria, Kirandeep Madan, Nihar Ajay Parikh, Rajneesh Kedarnath Anand

    • 16 Sep 20265 of 5 present3 independent · 18 days in between
    • 28 Aug 20265 of 5 present3 independent · 2 days in between
    • 25 Aug 20264 of 5 present3 independent · 17 days in between

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Mar 2026.

  • GMJ & Co.Peer-review certificate valid to Mar 2027

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Gujarat Themis Biosyn AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Gujarat Themis Biosyn dividend history

Annual general meeting, 30 Sep 2026

29,295 shareholders on the register on 23 Sep 2026; present: 7 promoters and 64 others; votes counted by Mr. Ketan Ravindra Shirwadkar / KRS AND CO..The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2026 together with Reports of the Board of Directors and Auditors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 75.64% · promoters 99.94% · institutions 72.27% · other public 18.38%

  2. To appoint a Director in place of Dr. Dinesh S. Patel (DIN: 00033273) who retires by rotation and being eligible, offers himself for re-appointment
    Ordinary
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 0.30% · other public 0.00%

    Turnout: all 75.64% · promoters 99.94% · institutions 72.27% · other public 18.38%

  3. To declare dividend on equity shares for the financial year ended 31st March, 2026.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 75.64% · promoters 99.94% · institutions 72.27% · other public 18.38%

  4. Ratification of Remuneration of Cost Auditor for the financial year 2026-27
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 75.64% · promoters 99.94% · institutions 72.27% · other public 18.38%

  5. Payment of Commission to Dr. Dinesh S. Patel (DIN: 00033273) Non-Executive Chairman
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 75.64% · promoters 99.94% · institutions 72.27% · other public 18.38%

  6. Payment of Commission to Dr. Sachin D. Patel (DIN: 00033353).
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.01% · other public 0.00%

    Turnout: all 75.64% · promoters 99.94% · institutions 72.27% · other public 18.38%

  7. Approval to avail loan and guarantee from Promoters / Promoters Group to finance acquisition / growth opportunities.
    OrdinaryNot passedPromoters have an interest in it
    40.14% for59.86% against

    Against: promoters 0.00% · institutions 81.57% · other public 0.00%

    Turnout: all 16.22% · promoters 0.00% · institutions 72.27% · other public 17.84%

  8. Raising funds by issue of Equity Shares through Preferential Issue.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.01% · other public 0.00%

    Turnout: all 75.64% · promoters 99.94% · institutions 72.27% · other public 18.38%

  9. Amendment in Articles of Association of the Company
    Special
    87.15% for12.85% against

    Against: promoters 0.00% · institutions 85.05% · other public 0.00%

    Turnout: all 75.08% · promoters 99.94% · institutions 68.88% · other public 18.38%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Extraordinary general meeting, 22 Aug 2026, 3 resolutions

27,788 shareholders on the register on 15 Aug 2026; present: 6 promoters and 50 others; votes counted by Mr. Ketan Ravindra Shirwadkar / KRS AND CO..The company's voting result (opens in a new tab)

  1. Approval of Material Related Party Transactions with Promoter / Promoter group entities.
    OrdinaryPromoters have an interest in it
    76.69% for23.31% against

    Against: promoters 0.00% · institutions 100.00% · other public 0.01%

    Turnout: all 5.04% · promoters 0.00% · institutions 40.36% · other public 14.74%

  2. Amendment to the Articles of Association of the Company
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 72.64% · promoters 95.17% · institutions 40.36% · other public 15.34%

  3. Private Placement of NCDs and/or Debt securities
    Special
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 1.93% · other public 0.00%

    Turnout: all 72.64% · promoters 95.17% · institutions 40.36% · other public 15.34%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 22 Aug 2026, 3 resolutions

27,809 shareholders on the register on 10 Jul 2026; votes counted by Mr. Ketan Ravindra Shirwadkar / KRS AND CO..The company's voting result (opens in a new tab)

  1. Raising funds by issue of Equity Shares through Qualified Institutions Placement.
    Special
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 1.45% · other public 0.08%

    Turnout: all 71.46% · promoters 95.85% · institutions 40.04% · other public 9.00%

  2. Amendment to the Articles of Association of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.09%

    Turnout: all 71.46% · promoters 95.85% · institutions 40.04% · other public 9.00%

  3. 3 - Private placement of NCDs and/or Debt securities.
    Special
    99.97% for0.03% against

    Against: promoters 0.00% · institutions 1.45% · other public 0.10%

    Turnout: all 71.46% · promoters 95.85% · institutions 40.04% · other public 9.00%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 8 Jul 2026, 1 resolution

27,661 shareholders on the register on 5 Jun 2026; votes counted by Mr. Ketan Ravindra Shirwadkar / KRS AND CO..The company's voting result (opens in a new tab)

  1. Raising funds by issue of Equity Shares through Qualified Institutions Placement:
    Special
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 1.46% · other public 0.02%

    Turnout: all 72.96% · promoters 99.14% · institutions 39.73% · other public 5.81%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 4 Jun 2026, 2 resolutions

28,042 shareholders on the register on 1 May 2026; votes counted by Mr. Ketan Ravindra Shirwadkar / KRS AND CO..The company's voting result (opens in a new tab)

  1. To approve increase in borrowing limits of the Company under section 180(1)(c) and creation of mortgage or charge on the assets, properties or undertaking(s) of the Company under section 180(1)(a) of the Companies Act, 2013MoreLess
    Special
    98.39% for1.61% against

    Against: promoters 0.00% · institutions 99.95% · other public 0.05%

    Turnout: all 72.82% · promoters 99.14% · institutions 39.76% · other public 5.32%

  2. To approve the limits to give loans/guarantees/investments or provide security in connection with loan(s) made to any person(s) or body corporate or person and acquire by way of subscription, purchase or otherwise the securities of any other body corporate in excess of the limits prescribed in Section 186 of the Companies Act, 2013.MoreLess
    SpecialPromoters have an interest in it
    98.38% for1.62% against

    Against: promoters 0.00% · institutions 99.95% · other public 0.43%

    Turnout: all 72.83% · promoters 99.14% · institutions 39.76% · other public 5.34%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 17 Apr 2026, 2 resolutions

24,740 shareholders on the register on 13 Mar 2026; votes counted by Mr. Ketan Ravindra Shirwadkar / KRS AND CO.The company's voting result (opens in a new tab)

  1. Re-appointment of Mrs. Kirandeep Madan (DIN: 00686547) as Non-Executive Woman Independent Director of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.21%

    Turnout: all 72.81% · promoters 99.09% · institutions 39.45% · other public 5.42%

  2. Approval of Material Related Party Transactions with Themis Medicare Limited (TML)
    OrdinaryPromoters have an interest in it
    52.56% for47.44% against

    Against: promoters 0.00% · institutions 98.47% · other public 0.20%

    Turnout: all 2.43% · promoters 0.00% · institutions 39.45% · other public 4.83%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 6 Feb 2026, 1 resolution

27,989 shareholders on the register on 2 Jan 2026; votes counted by Mr. Ketan Ravindra Shirwadkar / KRS AND CO.The company's voting result (opens in a new tab)

  1. To approve the appointment of Mr. Rajneesh Anand (DIN: 00134856) as Non-Executive Non-Independent Director
    Special
    98.39% for1.61% against

    Against: promoters 0.00% · institutions 98.54% · other public 1.08%

    Turnout: all 71.54% · promoters 99.25% · institutions 37.21% · other public 0.14%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 12 Sep 2025, 10 resolutions

28,930 shareholders on the register on 5 Sep 2025; present: 6 promoters and 55 others; votes counted by Mr. Ketan Shirwadkar / KRS AND CO..The company's voting result (opens in a new tab)

  1. To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2025 together with Reports of the Board of Directors and Auditors thereon.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 73.28% · promoters 100.00% · institutions 28.72% · other public 5.03%

  2. To appoint a Director in place of Dr. Dinesh S. Patel (DIN: 00033273) who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.11%

    Turnout: all 73.19% · promoters 99.88% · institutions 28.72% · other public 5.03%

  3. To declare dividend on equity shares for the financial year ended 31st March, 2025.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 73.28% · promoters 100.00% · institutions 28.72% · other public 5.03%

  4. Ratification of Remuneration of Cost Auditor for the financial year 2025-26
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 73.28% · promoters 100.00% · institutions 28.72% · other public 5.03%

  5. Appointment of Secretarial Auditor
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 73.28% · promoters 100.00% · institutions 28.72% · other public 5.03%

  6. Appointment and re-designation of Dr. Sachin D. Patel (DIN: 00033353) as Managing Director of the Company:
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.15% · other public 0.00%

    Turnout: all 72.68% · promoters 99.14% · institutions 28.72% · other public 5.03%

  7. Payment of Commission to Dr. Dinesh S. Patel (DIN: 00033273) Non-Executive Chairman
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.11% · other public 0.14%

    Turnout: all 72.68% · promoters 99.14% · institutions 28.72% · other public 5.03%

  8. Payment of Commission to Dr. Sachin D. Patel (DIN: 00033353)
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.11% · other public 0.03%

    Turnout: all 72.68% · promoters 99.14% · institutions 28.72% · other public 5.03%

  9. Appointment of Mr. Nihar Ajay Parikh (DIN: 02475787) as an Independent Director of the Company:
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 73.28% · promoters 100.00% · institutions 28.72% · other public 5.03%

  10. Payment of Commission to Independent Directors
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.03%

    Turnout: all 73.28% · promoters 100.00% · institutions 28.72% · other public 5.03%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 4 Jun 2026, 3 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To approve the limits to give loans/guarantees/investments or provide security in connection with loan(s) made to any person(s) or body corporate or person and acquire by way of subscription, purchase or otherwise the securities of any other body corporate in excess of the limits prescribed in Section 186 of the Companies Act, 2013.MoreLess
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund, quant Mutual Fund
    • Bandhan Mutual FundCompliant with law. Governance & Transparency Concern: Lack of adequate justifications & disclosure as the Company has not provided details of the recipients. Umbrella approval to cover any person/entity in the proposed limit.
    • Motilal Oswal Mutual FundInadequate justifications & disclosures; Umbrella approval being sought.
    • quant Mutual FundCompliant with the law. Governance & transparency concern: Lack of adequate justifications & disclosure as the company has not provided details of the recipients. Umbrella approval to cover any person/ entity in the proposed limit.
    0 for3 against
2 proposals not matched to one resolution
  • 1. To borrow and raise such sums of money from bank and/or other non-banking financial lenders and/or any corporates and/or other financial institutions and lenders (as permitted under applicable laws) in the form of term loans (short term/ long term), cash credit, overdraft facility, working capital demand loan etc., external commercial borrowings in Indian rupees or equivalent thereof in any foreign currency (ies), rupee denominated bonds issued outside India / overseas or otherwise or in any foreign currency (ies) as permitted by the applicable laws, by issue of commercial paper and by issue of non-convertible debentures in one or more tranches/ series, from time to time, and with or without security, including commercial terms as may be determined by the Board of Directors on the basis of the prevailing market conditions, and as may be required for the purposes of the business of the Company, in excess of the aggregate of the paid-up capital of the Company, free reserves of the Company, that is to say, reserves not set apart for any specific purpose and the securities premium, at a maximum limit subject to the proviso that such borrowings, together with monies already borrowed, shall not at any one time exceed Rs. 3,500 Crores excluding all temporary loans obtained by the Company from its bankers in the ordinary course of its business.MoreLess
    Against quant Mutual Fund
    • quant Mutual FundCompliant with the law. Governance & transparency concern: Considering the significantly enhanced borrowing limits vis-à-vis the company's financial capacity and inadequate justification w.r.t. the remaining utilization as the objective of the increase in borrowing limits does not justify increasing the borrowing limits by 35x.
    0 for1 against
  • To borrow and raise such sums of money from bank and/or other non-banking financial lenders and/or any corporates and/or other financial institutions and lenders (as permitted under applicable laws) in the form of term loans (short term/ long term), cash credit, overdraft facility, working capital demand loan etc., external commercial borrowings in Indian rupees or equivalent thereof in any foreign currency (ies), rupee denominated bonds issued outside India / overseas or otherwise or in any foreign currency (ies) as permitted by the applicable laws, by issue of commercial paper and by issue of non-convertible debentures in one or more tranches/ series, from time to time, and with or without security, including commercial terms as may be determined by the Board of Directors on the basis of the prevailing market conditions, and as may be required for the purposes of the business of the Company, in excess of the aggregate of the paid-up capital of the Company, free reserves of the Company, that is to say, reserves not set apart for any specific purpose and the securities premium, at a maximum limit subject to the proviso that such borrowings, together with monies already borrowed, shall not at any one time exceed Rs. 3,500 Crores excluding all temporary loans obtained by the Company from its bankers in the ordinary course of its business.MoreLess
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual FundCompliant with law. Governance & Transparency Concern: Considering the significantly enhanced borrowing limits vis-à-vis the Company’s financial capacity and inadequate justification w.r.t the remaining utilization as the objective of the increase in borrowing limits does not justify increasing the borrowing limits by ~35x.
    • Motilal Oswal Mutual FundInadequate rationale for partial utilization and lack of clarity to sustain the limits.
    0 for2 against

Mutual fund votes, meeting of 17 Apr 2026, 3 fund houses

  • Re-appointment of Mrs. Kirandeep Madan (DIN: 00686547) as Non-Executive Woman Independent Director of the Company.
    3 for0 against
  • Approval of Material Related Party Transactions with Themis Medicare Limited (TML)
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund, quant Mutual Fund
    • Bandhan Mutual FundCompliant with law. Governance concern: Proposed Limits are not in line with previous year RPT Quantum and no justification has been provided for the same.
    • Motilal Oswal Mutual FundNo justification for significant shift in limits of RPTs proposed
    • quant Mutual FundCompliant with the law. Governance concern: Proposed limits are not in line with previous year RPT Quantum and no justification has been provided for the same
    0 for3 against
2 earlier meetings

Mutual fund votes, meeting of 6 Feb 2026, 3 fund houses

  • To approve the appointment of Mr. Rajneesh Anand (DIN: 00134856) as Non-Executive Non-Independent Director
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund, quant Mutual Fund
    • Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance & Transparency concern: Proposed professional fee appears to be excessive when compared with the remuneration paid to KMP roles. Inadequate disclosures regarding the basis of arriving at the proposed pay. Fairness cannot be ascertained.
    • quant Mutual FundIn relation to the appointment of Mr Rajneesh Anand as Non-Executive Non-Independent Director. Compliant with law. Governance & transparency concern: Proposed professional fee appears to be excessive when compared with the remuneration paid to KMP roles. Inadequate disclosures regarding the basis of arriving at the proposed pay. Fairness cannot be ascertained. Hence, we are voting against the resolution.
    0 for3 against

Mutual fund votes, meeting of 12 Sep 2025, 3 fund houses

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

  • To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2025 together with Reports of the Board of Directors and Auditors thereon.
    3 for0 against
  • To appoint a Director in place of Dr. Dinesh S. Patel (DIN: 00033273) who retires by rotation and being eligible, offers himself for re-appointment.
    3 for0 against
  • To declare dividend on equity shares for the financial year ended 31st March, 2025.
    3 for0 against
  • Ratification of Remuneration of Cost Auditor for the financial year 2025-26
    3 for0 against
  • Appointment of Secretarial Auditor
    2 for0 against
  • Appointment and re-designation of Dr. Sachin D. Patel (DIN: 00033353) as Managing Director of the Company:
    Against Bandhan Mutual Fund
    • Bandhan Mutual FundDr. Sachin D. Patel, 50, part of the promoter group, has been on the board since 2008, in a non-independent capacity. The company proposes to redesignate him to Managing Director. During FY25, he attended all seven board meetings. He also serves as Managing Director & CEO - Themis Medicare Limited (TML) – a group company. Given his role and responsibilities in both companies requires him to devote time to the affairs of both GTBL and TML he will draw remuneration from both. His remuneration from TML for FY25 was Rs. 16.4 mn. His proposed remuneration as Managing Director - GTBL comprises fixed pay ranging between Rs. 12.0 mn to 18.0 mn annually and commission as determined by NRC. Given the lack of clarity on commission , we are unable to ascertain his remuneration . The company must put an absolute cap on commission and disclose performance metrics basis which commission will be paid. We do not support the resolution.
    2 for1 against
  • Payment of Commission to Dr. Dinesh S. Patel (DIN: 00033273) Non-Executive Chairman
    3 for0 against
  • Payment of Commission to Dr. Sachin D. Patel (DIN: 00033353)
    3 for0 against
  • Appointment of Mr. Nihar Ajay Parikh (DIN: 02475787) as an Independent Director of the Company:
    3 for0 against
  • Payment of Commission to Independent Directors
    3 for0 against
1 proposal not matched to one resolution
  • 5. Ordinary Resolution :Appointment of SecretarialAuditor.
    1 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

At most 1 complaint open, quarter to Sep 2026.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it.